Rethinking pharma productivity
Many companies’ efforts to do more with less have stalled. Six situations present opportunities for executives to reignite programs that optimize efficiency and cost. ...
How tech-enabled consumers are reordering the healthcare landscape
Healthcare companies are developing new digital technologies to give consumers more control over the care they receive. That could upend the industry’s move toward greater consolidation and scale.
Closing the digital gap in pharma
New research on the digital maturity of pharma, relative to other industries, reveals clear opportunities to improve performance by better connecting digitally with patients and physicians.
Health systems: Improving and sustaining quality through digital transformation
As the price of healthcare rises and safety lapses persist, developed countries are seeking ways to lower costs and improve quality. Many are finding the solution in digital innovation.
Change lessons from pharma and med tech
Industry leaders emphasize the importance of four management practices in a transformation.
Unlocking the potential of frontline managers in global health
Health systems in developing countries have a big opportunity to improve the provision of services by strengthening the capabilities of their frontline managers.
Why digital transformation should be a strategic priority for health insurers
Digital technologies and applications have the potential to markedly enhance a payor’s profits. Leadership from the top is necessary to overcome the organizational resistance to change that can...
How pharma companies can better understand patients
Consumers have access to more healthcare information than ever. Here’s how pharmaceutical companies can better understand the way people make decisions about their care.
Verso un modello value based a sostegno della Digital Health
La degli esperti di McKinsey & Company per aiutare i sistemi sanitari nazionali a sfruttare le chance della digitalizzazione.
Digital Health - A Big Pharma serve un cambio di mentalità
Un report di McKinsey & Company raccoglie le interviste di 20 opinion leader del settore sui nuovi scenari della sanità digitale.
Pharma M&A: Agile shouldn’t mean ad hoc
Under pressure to be active acquirers, some pharmaceutical and medical-products companies may be neglecting best practices. Here’s where they can most improve.
How healthcare systems can become digital-health leaders
The potential of digitization is well understood, yet healthcare systems are struggling to convert ambition into reality. Here’s what we recommend.
How pharma can win in a digital world
The digital revolution is well under way for pharma companies. We spoke with 20 leading executives to find out how they cope—and what they do to stay ahead.
Debunking common myths about healthcare consumerism
Consumers are taking an increasingly active role in healthcare decision making. What does that mean for payors and providers? We separate fact from fiction.
The road to digital success in pharma
Pharmaceutical companies can play a central role in the digital revolution of healthcare. But capturing this opportunity requires identifying the right initiatives.